Chief Scientific Officer
Thu, Jun 11, 2026
Jun 11
18,586 shares @ $38.06
Decreased holdings by -7.50%
3rd largest trade (out of 7)
Planned (10b5-1)
“The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 20% above 200-day moving average
INDVIndivior Pharmaceuticals, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+0.72%
1M-2.87%
3M—
6M—
1Y—